Should pharmaceutical companies be doing more to advocate open access?
Many public funders have mandated open access to their research and support Plan S. Should pharmaceutical companies follow suit?
Can holding institution heads to account lead to improved rates of clinical trial reporting?
AllTrials seeks support for a new initiative to monitor clinical trial reporting in the UK.
Are we delivering on transparency and reproducibility?
Transparency and reproducibility are now synonymous with medical publications, but actions speak louder than words. A recent study examines whether progress has been made.
The latest updates to ICMJE’s reporting recommendations
The ICMJE recently updated its recommendations, providing guidance on issues such as use of preprint servers, conflict of interest reporting and journal metrics.
Free webinar on open access publishing
A free 90-minute webinar from ISMPP, open to all.
Wellcome prizes up for grabs for innovative re-use of open data
Researchers can win Wellcome Data Re-use Prizes for new insights, tools or health applications generated from re-use of open data.
Are researchers able to access trial data? Audit provides insights on data sharing from industry-sponsored studies
A recent study published in BMC Medicine audits data sharing from pharmaceutical industry-sponsored clinical studies.
2018 World Science Day for Peace and Development: Science, a Human Right
UNESCO World Science Day for Peace and Development aims to improve access and diversity in science.
The Wellcome Trust announces a new open access policy
The Wellcome Trust announces a new open access policy, which includes five key updates.
[VIDEO] Faster future: preprints
Tim Ellison reviews the growing importance of preprints in medical publishing.
2018 International Open Access Week has arrived!
This year’s International Open Access Week (October 22–28) is underway with a focus on designing equitable foundations for open knowledge. A host of events are scheduled across the globe, how will you get involved?
Should academics be rewarded for communicating their research to the public?
We consider if enough value is placed by academic institutions on efforts to communicate science to the public.
Exploring the pros and cons of funder open access platforms
In a recent publication, researchers examine whether funder open access platforms are a good idea.
Open access for all scientific papers by 2020: an impossible target?
Robert-Jan Smits, a senior European Commission official comments on whether open access for all scientific papers by 2020 is a realistic goal.
ASCO journals now offer open access for publications of industry-sponsored research
In a recent MAP newsletter, ISMPP share an update from ASCO on their new open access option for industry-funded research.
[VIDEO] Preprints and peer review – feedback from the 14th Annual Meeting of ISMPP
Mary Yianni, Publisher at Taylor and Francis, reviews the different models of peer review and the emerging role of preprints.